Protagonic Therapeutics, Inc. Warrant

Protagonic Therapeutics, Inc. Warrant is a financial instrument that provides its holder the right, but not the obligation, to purchase shares of Protagonic Therapeutics, Inc. at a predetermined price before a specified expiration date. Warrants are typically issued by the company alongside securities as a means to raise capital or as an incentive for investors. Protagonic Therapeutics, Inc. is involved in the biotechnology sector, focusing on the discovery and development of innovative therapeutics targeting challenging medical conditions. The key feature of this warrant is its ability to offer potential future equity participation in Protagonic Therapeutics, allowing investors to capitalize on the company's advancements and growth within the biopharmaceutical industry. This warrant plays a crucial role in the financial markets by providing leverage, which can amplify potential returns, and as a strategic tool for portfolio diversification. By engaging with such warrants, investors gain exposure to early or developmental-stage biotechnological innovations, thus participating in a sector known for its high-risk, high-reward profile.